Nuvectra(NVTR) had an awful first week following its spinoff from Greatbatch(GB), as we pointed out last Friday. At Friday’s close, it was trading well below its cash position, and it carries no debt. Investors who sought to exploit this spread have been rewarded today with a steadily rising stock that has risen over 30%. The stock trades below cash, but the margin of safety is now greatly reduced. Anyone have any thoughts on the company’s actual business? Is there promise in the Algovita SCS?
Disclosure: The author holds no shares of any stock mentioned.